NO20092530L - Genetiske markorer for risikohandtering av hjertearrytmi - Google Patents

Genetiske markorer for risikohandtering av hjertearrytmi

Info

Publication number
NO20092530L
NO20092530L NO20092530A NO20092530A NO20092530L NO 20092530 L NO20092530 L NO 20092530L NO 20092530 A NO20092530 A NO 20092530A NO 20092530 A NO20092530 A NO 20092530A NO 20092530 L NO20092530 L NO 20092530L
Authority
NO
Norway
Prior art keywords
cardiac arrhythmia
atrial fibrillation
risk management
genetic markers
markers
Prior art date
Application number
NO20092530A
Other languages
English (en)
Inventor
Anna Helgadottir
Daniel Gudbjartsson
Original Assignee
Decode Genetics Ehf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IS8576A external-priority patent/IS8576A/is
Application filed by Decode Genetics Ehf filed Critical Decode Genetics Ehf
Publication of NO20092530L publication Critical patent/NO20092530L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/40—Population genetics; Linkage disequilibrium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Physiology (AREA)
  • Ecology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Chemical Kinetics & Catalysis (AREA)

Abstract

Oppfinnelsen vedrører fremgangsmåte og prosedyre for å bestemme en mottakelighet for hjertearytmi, inkludert atrieflimmer, atrieflutter og slag, ved å vurdere nærvær eller fravær av alleler ved polymorfe markører som man har funnet er assosiert med atrieflimmer, atrieflutter og slag. Oppfinnelsen vedrører ytterligere sett omfattende reagenser for vurdering av slike markører og diagnostiseringsfremgangsmåter, anvendelse og prosedyrer for å bruke slike mottakelighetsmarkører.
NO20092530A 2006-12-05 2009-07-03 Genetiske markorer for risikohandtering av hjertearrytmi NO20092530L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IS8576A IS8576A (is) 2006-12-05 2006-12-05 Genetic susceptibility variants of atrial fibrillation and stroke
IS8658 2007-06-29
PCT/IS2007/000021 WO2008068780A2 (en) 2006-12-05 2007-12-05 Genetic markers for risk management of cardiac arrhythmia

Publications (1)

Publication Number Publication Date
NO20092530L true NO20092530L (no) 2009-09-03

Family

ID=39133840

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20092530A NO20092530L (no) 2006-12-05 2009-07-03 Genetiske markorer for risikohandtering av hjertearrytmi

Country Status (15)

Country Link
US (2) US8637244B2 (no)
EP (1) EP2121979B1 (no)
JP (1) JP5646174B2 (no)
KR (2) KR101582321B1 (no)
AU (1) AU2007330306B2 (no)
BR (1) BRPI0720116B8 (no)
CA (1) CA2673123C (no)
DK (1) DK2121979T3 (no)
EA (1) EA017529B1 (no)
IL (1) IL199049A (no)
MX (1) MX2009005651A (no)
NO (1) NO20092530L (no)
NZ (1) NZ577805A (no)
SG (1) SG177185A1 (no)
WO (1) WO2008068780A2 (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101582321B1 (ko) * 2006-12-05 2016-01-05 디코드 제네틱스 이에이치에프 심장성 부정맥의 위험 관리를 위한 유전적 마커
WO2010086697A1 (en) * 2009-01-30 2010-08-05 Bio-Rad Pasteur Method for the in vitro diagnosis of stroke
CA2757384A1 (en) 2009-04-03 2010-10-07 Decode Genetics Ehf. Determination of genetic risk of atrial fibrillation and stroke associated with rs7193343 and correlated markers
WO2011042920A1 (en) * 2009-10-07 2011-04-14 Decode Genetics Ehf Genetic variants indicative of vascular conditions
CA2793210A1 (en) * 2010-03-19 2011-09-22 Cardiodx, Inc. Determining susceptibility to a sudden cardiac event
WO2011153428A1 (en) * 2010-06-03 2011-12-08 Medtronic, Inc. System and method for assessing a likelihood of a patient to experience a future cardiac arrhythmia using dynamic changes in a biological parameter
WO2012000119A1 (en) * 2010-07-02 2012-01-05 Prognomix Inc. A method of determining a predisposition to atrial fibrillation in a subject
CA2843582A1 (en) * 2010-07-29 2012-02-02 The Board Of Trustees Of The University Of Illinois Methods for predicting risk of stroke
KR101230088B1 (ko) * 2010-11-24 2013-02-05 연세대학교 산학협력단 심방세동의 예후 예측 방법
KR101331787B1 (ko) * 2011-10-04 2013-11-21 한국과학기술연구원 심장 부정맥 진단용 바이오마커 및 이를 이용한 심장 부정맥 진단 방법
ES2595028T3 (es) 2011-10-17 2016-12-27 F. Hoffmann-La Roche Ag Diagnóstico basado en Troponina y BNP de pacientes en riesgo y causa de ictus
US20140364334A1 (en) * 2011-12-21 2014-12-11 Nuclea Biotechnologies, Inc. Congestive heart failure biomarkers
KR101462006B1 (ko) * 2013-07-23 2014-11-18 한국과학기술연구원 심장 부정맥 진단용 바이오마커 및 이를 이용한 심장 부정맥 진단 방법
US9393177B2 (en) 2013-08-20 2016-07-19 Anutra Medical, Inc. Cassette assembly for syringe fill system
USD750768S1 (en) 2014-06-06 2016-03-01 Anutra Medical, Inc. Fluid administration syringe
USD774182S1 (en) 2014-06-06 2016-12-13 Anutra Medical, Inc. Anesthetic delivery device
USD763433S1 (en) 2014-06-06 2016-08-09 Anutra Medical, Inc. Delivery system cassette
AU2015314956A1 (en) 2014-09-11 2017-04-06 Berg Llc Bayesian causal relationship network models for healthcare diagnosis and treatment based on patient data
US10678367B1 (en) * 2015-09-11 2020-06-09 Apple Inc. Compressive touch sensing
WO2017053915A1 (en) * 2015-09-24 2017-03-30 Caris Science, Inc. Method, apparatus, and computer program product for analyzing biological data
KR101883657B1 (ko) * 2016-05-13 2018-07-31 연세대학교 산학협력단 단일염기다형성에 의한 심방세동의 예측 또는 진단에 관한 정보 제공 방법
RU2657942C1 (ru) * 2017-07-25 2018-06-18 Федеральное государственное бюджетное образовательное учреждение высшего образования Читинская государственная медицинская академия Министерства здравоохранения российской федерации Способ прогнозирования риска развития фибрилляции предсердий у женщин с ишемической болезнью сердца
RU2664430C1 (ru) * 2017-12-14 2018-08-17 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ прогнозирования риска развития инсульта у мужчин на основе генетического тестирования
CN109324189B (zh) * 2018-08-15 2021-10-01 泰达国际心血管病医院 多蛋白组合物的应用及先天性心脏病筛查试剂盒
US20210393592A1 (en) * 2018-11-02 2021-12-23 Celltrion Inc. Pharmaceutical composition for use in treatment of hypertrophic cardiomyopathy
JP7165100B2 (ja) * 2019-04-23 2022-11-02 ジェネシスヘルスケア株式会社 心房細動及び／又は心室細動のリスクを判定する方法
WO2021118796A1 (en) * 2019-12-13 2021-06-17 Ischemia Care Llc Biomarkers for the diagnosis of atrial fibrillation cause of stroke
KR102250719B1 (ko) * 2020-01-07 2021-05-11 고려대학교 산학협력단 발작성 심방세동 환자의 재발 위험도 예측을 위한 바이오 마커
US20230332236A1 (en) * 2020-10-08 2023-10-19 Ischemia Care Llc Method for diagnosing stroke utilizing gene expression signatures
KR20230092953A (ko) * 2020-10-20 2023-06-26 지네틱 테크놀로지스 리미티드 질병 발병의 위험을 평가하는 방법

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US5288611A (en) * 1983-01-10 1994-02-22 Gen-Probe Incorporated Method for detecting, identifying, and quantitating organisms and viruses
EP0756010B1 (en) * 1983-01-10 2001-07-04 Gen-Probe Incorporated Method for detecting, identifying, and quantitating organisms and viruses
EP1892296A1 (en) 1988-09-02 2008-02-27 Dyax Corporation Generation and selection of recombinant varied binding proteins
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5424186A (en) * 1989-06-07 1995-06-13 Affymax Technologies N.V. Very large scale immobilized polymer synthesis
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5288644A (en) * 1990-04-04 1994-02-22 The Rockefeller University Instrument and method for the sequencing of genome
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
DK0585287T3 (da) 1990-07-10 2000-04-17 Cambridge Antibody Tech Fremgangsmåde til fremstilling af specifikke bindingsparelementer
ATE164395T1 (de) 1990-12-03 1998-04-15 Genentech Inc Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
EP0562025B1 (en) 1990-12-06 2001-02-07 Affymetrix, Inc. (a Delaware Corporation) Compounds and their use in a binary synthesis strategy
JP4146512B2 (ja) 1991-03-01 2008-09-10 ダイアックス コープ． 小型タンパク質
DE4122599C2 (de) 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
US5384261A (en) * 1991-11-22 1995-01-24 Affymax Technologies N.V. Very large scale immobilized polymer synthesis using mechanically directed flow paths
WO1993022456A1 (en) 1992-04-27 1993-11-11 Trustees Of Dartmouth College Detection of gene sequences in biological fluids
US5858659A (en) * 1995-11-29 1999-01-12 Affymetrix, Inc. Polymorphism detection
US5837832A (en) * 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
WO2004028341A2 (en) 2001-03-19 2004-04-08 Decode Genetics Ehf. Susceptibility gene for human stroke; methods of treatment
KR101582321B1 (ko) * 2006-12-05 2016-01-05 디코드 제네틱스 이에이치에프 심장성 부정맥의 위험 관리를 위한 유전적 마커

Also Published As

Publication number Publication date
MX2009005651A (es) 2009-06-08
US8637244B2 (en) 2014-01-28
WO2008068780A3 (en) 2008-10-09
BRPI0720116A2 (pt) 2014-01-14
IL199049A (en) 2014-09-30
AU2007330306A1 (en) 2008-06-12
JP2010511404A (ja) 2010-04-15
DK2121979T3 (en) 2017-09-25
SG177185A1 (en) 2012-01-30
CA2673123A1 (en) 2008-06-12
CA2673123C (en) 2019-04-30
KR20150113216A (ko) 2015-10-07
JP5646174B2 (ja) 2014-12-24
EP2121979A2 (en) 2009-11-25
EA200970578A1 (ru) 2009-12-30
AU2007330306B2 (en) 2013-10-24
KR20090087494A (ko) 2009-08-17
BRPI0720116B8 (pt) 2021-07-27
US20140227693A1 (en) 2014-08-14
EA017529B1 (ru) 2013-01-30
US20090325163A1 (en) 2009-12-31
KR101582321B1 (ko) 2016-01-05
WO2008068780A2 (en) 2008-06-12
BRPI0720116B1 (pt) 2018-05-02
NZ577805A (en) 2012-09-28
EP2121979B1 (en) 2017-07-12

Similar Documents

Publication Publication Date Title
NO20092530L (no) Genetiske markorer for risikohandtering av hjertearrytmi
WO2010001419A3 (en) Copy number variations predictive of risk of schizophrenia
GB2477868A (en) Methods and systems for incorporating multiple environmental and genetic risk factors
WO2008132763A3 (en) Genetic variants useful for risk assessment of coronary artery disease and myocardial infarction
WO2008146309A3 (en) Genetic variants on chr 5pl2 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
WO2009038742A3 (en) Method for estimating risk of acute kidney injury
WO2009149319A3 (en) Gene expression profiles associated with asthma exacerbation attacks
PE20121029A1 (es) Marcadores de riesgo para enfermedad cardiovascular
EP3922731A3 (en) Methods and processes for non-invasive assessment of genetic variations
WO2011087760A3 (en) Processes and kits for identifying aneuploidy
BR112014031370A2 (pt) método para detectar e identificar escherichia coli enterohemorrágica
WO2012083004A3 (en) Blood-borne mirnas as surrogate markers of drug efficacy for cardiac conditions
WO2008148115A8 (en) Methods, systems, and kits for evaluating multiple sclerosis
WO2010041046A8 (en) Granin proteins as markers of heart disease
WO2011153354A8 (en) Methods and kits for in situ detection of nucleotide sequences
WO2008028031A3 (en) Markers and methods for assessing and treating ulcerative colitis and related disorders using a 43 gene panel
WO2013132074A3 (en) A genotyping test for assessing risk of autism
WO2016133380A8 (en) Methods and snp detection kits for predicting palm oil yield of a test oil palm plant
WO2009102748A3 (en) Alternatively transcribed genes associated with schizophrenia
WO2007006862A3 (en) Method and kit for detecting a risk of coronary heart disease
WO2013090386A3 (en) Methods and kits for room temperature in situ detection of a target nucleic acid in a biological sample
WO2005112568A3 (en) Haplotype markers and methods of using the same to determine response to treatment
WO2011020906A3 (en) sPLA2 IIA POLYMORPHISM ANALYSIS FOR THE DIAGNOSIS/PROGNOSIS OF A CARDIOVASCULAR DISEASE/EVENT
WO2010001358A3 (en) Diagnostic polymorphisms for cardiac disease
WO2012080359A3 (en) Mhc genes and risk of graft versus host disease

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application